Gene therapy trial aims to boost HIV fight in lymphoma patients
NCT ID NCT02337985
First seen Nov 10, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This early-stage study tests whether giving gene therapy after chemotherapy is safe for people with AIDS-related lymphoma. Ten participants will receive stem cells modified with anti-HIV genes to help their bodies fight the virus. The goal is to see if this approach can control both HIV and lymphoma without causing serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
NCI Lymphoid Malignancies Branch
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.